These Analysts Slash Their Forecasts On Equifax After Q2 Results - Equifax (NYSE:EFX)
Equifax reported Q2 adjusted EPS of $2.25, above the $2.20 consensus, and revenue of $1.70B, up 11% and slightly above the $1.696B estimate. It narrowed full-year adjusted EPS guidance to $8.39-$8.69 and tightened revenue outlook to $6.71B-$6.78B. For Q3, it forecast adjusted EPS $2.15-$2.25 and revenue $1.68B-$1.71B. Analysts cut price targets after results.
How this was made

The 30-second read
Why it matters
Traders can reassess expectations using the narrowed FY EPS and revenue ranges and the Q3 EPS range that sits below consensus.
Market read
Fresh guidance ranges and same-day analyst target reductions provide actionable inputs for short- to medium-term positioning in EFX.
What to watch
Analyst price targets were cut across multiple firms, but the article does not provide the underlying thesis for the cuts beyond the earnings/guidance numbers.
Background
The article follows Equifax’s Q2 results and focuses on updated full-year and Q3 guidance ranges.
Ticker impact
Equifax reported adjusted EPS of $2.25 and revenue of $1.70B, then narrowed FY guidance and set Q3 EPS below consensus.
Near-term downside bias versus consensus expectations, with volatility likely around the Q3 outlook.
The article cites FY EPS and revenue midpoint broadly in line with consensus, but Q3 adjusted EPS guidance ($2.15-$2.25) is below the $2.26 estimate and shares fell 2.5%.
Market effects
Credit bureau and consumer data services peers may see read-across on demand and pricing assumptions, but this is company-specific guidance.
Limited regional spillover; guidance is reported in local currency and US-listed equity reaction dominates.
Low global relevance beyond the credit reporting services space.
Counterpoint
FY guidance midpoints are broadly in line with consensus, so the selloff may be overdone if investors focus on full-year stability rather than Q3.
Key entities
- companyEquifax
Reported Q2 adjusted EPS and revenue, narrowed FY guidance, and guided Q3 adjusted EPS below consensus.
- analyst_firmNeedham
Maintained Buy rating and lowered price target from $265 to $245 after the earnings announcement.
- analyst_firmBarclays
Maintained Equal-Weight rating and cut price target from $215 to $200.
- analyst_firmRBC Capital
Maintained Outperform rating and lowered price target from $222 to $194.


